Heart allograft rejection: detection with breath alkanes in low levels (the HARDBALL study).

[1]  Ingolf Schimke,et al.  Oxidative stress in the human heart is associated with changes in the antioxidative defense as shown after heart transplantation , 2004, Molecular and Cellular Biochemistry.

[2]  V. Falk,et al.  Upregulation of Bcl-2 Through Caspase-3 Inhibition Ameliorates Ischemia/Reperfusion Injury in Rat Cardiac Allografts , 2001, Circulation.

[3]  M. Phillips,et al.  Effect of age on the breath methylated alkane contour, a display of apparent new markers of oxidative stress. , 2000, The Journal of laboratory and clinical medicine.

[4]  S. Lipsitz,et al.  Non-invasive assessment of rejection in pediatric transplant patients: serologic and echocardiographic prediction of biopsy-proven myocardial rejection. , 2000, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[5]  M. Phillips,et al.  Effect of age on the profile of alkanes in normal human breath , 2000, Free radical research.

[6]  M. Phillips,et al.  Variation in volatile organic compounds in the breath of normal humans. , 1999, Journal of chromatography. B, Biomedical sciences and applications.

[7]  R. Ferrari,et al.  Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: experimental studies. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[8]  A. Keogh,et al.  Unbound cyclosporine and allograft rejection after heart transplantation. , 1999, Transplantation.

[9]  J. Kucharská,et al.  Coenzyme Q10 depletion and mitochondrial energy disturbances in rejection development in patients after heart transplantation , 1999, BioFactors.

[10]  A. Ohta,et al.  Cloning and characterization of an n‐alkane‐inducible cytochrome P450 gene essential for n‐decane assimilation by Yarrowia lipolytica , 1998, Yeast.

[11]  J. Ehtisham,et al.  Optimum maintenance trough levels of cyclosporine in heart transplant recipients given corticosteroid-free regimen. , 1998, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[12]  B. Kemper,et al.  Regulation of cytochrome P450 gene transcription by phenobarbital. , 1998, Progress in nucleic acid research and molecular biology.

[13]  J. Bucher,et al.  Do endogenous volatile organic chemicals measured in breath reflect and maintain CYP2E1 levels in vivo? , 1997, Toxicology and applied pharmacology.

[14]  M. Phillips.  Method for the collection and assay of volatile organic compounds in breath. , 1997, Analytical biochemistry.

[15]  B. Keevil,et al.  Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection? , 1997, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[16]  B. McManus,et al.  Consistencies and controversies in the application of the International Society for Heart and Lung Transplantation working formulation for heart transplant biopsy specimens. Rapamycin Cardiac Rejection Treatment Trial Pathologists. , 1996, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[17]  J. Ramsey,et al.  Breath pentane and heart rejection. , 1994, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[18]  J. Narula,et al.  Antibody imaging in the evaluation of cardiovascular diseases , 1994, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[19]  P. Watkins,et al.  P450 3A activity and cyclosporine dosing in kidney and heart transplant recipients , 1994, Clinical pharmacology and therapeutics.

[20]  C. Kneepkens,et al.  The potential of the hydrocarbon breath test as a measure of lipid peroxidation. , 1994, Free radical biology & medicine.

[21]  M. Phillips,et al.  Alveolar gradient of pentane in normal human breath. , 1994, Free radical research.

[22]  Sobotka Pa,et al.  Breath pentane is a marker of acute cardiac allograft rejection. , 1994 .

[23]  D. Kohlmüller,et al.  Is n-pentane really an index of lipid peroxidation in humans and animals? A methodological reevaluation. , 1993, Analytical biochemistry.

[24]  J. Kraner,et al.  Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. , 1993, Critical reviews in toxicology.

[25]  A. Cailleux,et al.  Is pentane a normal constituent of human breath? , 1993, Free radical research communications.

[26]  M. Phillips,et al.  Breath tests in medicine. , 1992, Scientific American.

[27]  C. Kneepkens,et al.  The hydrocarbon breath test in the study of lipid peroxidation: principles and practice. , 1992, Clinical and investigative medicine. Medecine clinique et experimentale.

[28]  M. Hammond,et al.  A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. , 1990, The Journal of heart transplantation.

[29]  T. Hintze,et al.  Cytochrome P-450 oxidation of alkanes originating as scission products during lipid peroxidation. , 1984, Xenobiotica; the fate of foreign compounds in biological systems.

[30]  J. Losman.  The International Society for Heart Transplantation , 1982 .